Literature DB >> 18493868

Human papilloma virus (HPV) and host cellular interactions.

Ioannis N Mammas1, George Sourvinos, Athena Giannoudis, Demetrios A Spandidos.   

Abstract

Viral-induced carcinogenesis has been attributed to the ability of viral oncoproteins to target and interact with the host cellular proteins. It is generally accepted that Human papilloma virus (HPV) E6 and E7 function as the dominant oncoproteins of 'high-risk' HPVs by altering the function of critical cellular proteins. Initially it was shown that HPV E6 enhances the degradation of p53, while HPV E7 inactivates the function of the retinoblastoma tumor suppressor protein Rb. However, recent studies during the last decade have identified a number of additional host cellular targets of both HPV E6 and E7 that may also play an important role in malignant cellular transformation. In this review we present the interactions of HPV E6 and E7 with the host cellular target proteins. We also present the role of DNA integration in the malignant transformation of the epithelial cell.

Entities:  

Mesh:

Year:  2008        PMID: 18493868     DOI: 10.1007/s12253-008-9056-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  112 in total

1.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Authors:  William Alazawi; Mark Pett; Barbara Arch; Laurie Scott; Tom Freeman; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  The human papillomavirus E7 protein shines a spotlight on the pRB family member, p130.

Authors:  Ann Roman
Journal:  Cell Cycle       Date:  2006-03-15       Impact factor: 4.534

3.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.

Authors:  M Thomas; L Banks
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

5.  Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.

Authors:  Edio Maldonado; María Eugenia Cabrejos; Lawrence Banks; Jorge E Allende
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

6.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.

Authors:  Frauke Fehrmann; Laimonis A Laimins
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

9.  Inhibition of Bak-induced apoptosis by HPV-18 E6.

Authors:  M Thomas; L Banks
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

10.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  21 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97.

Authors:  Celestine N Chi; Anders Bach; Åke Engström; Kristian Strømgaard; Patrik Lundström; Neil Ferguson; Per Jemth
Journal:  J Biol Chem       Date:  2010-11-27       Impact factor: 5.157

3.  HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Authors:  Dorota Pastuszak-Lewandoska; Anna Bartosińska-Dyc; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Daria Domańska; Krzysztof Szyłło; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2014-01-17       Impact factor: 3.064

Review 4.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

5.  Human Papilloma Virus Infection Does Not Predict Response to Interferon Therapy in Ocular Surface Squamous Neoplasia.

Authors:  Anat Galor; Nisha Garg; Afshan Nanji; Madhura Joag; Gerard Nuovo; Sotiria Palioura; Gaofeng Wang; Carol L Karp
Journal:  Ophthalmology       Date:  2015-09-01       Impact factor: 12.079

Review 6.  Diversity and evolution of chromatin proteins encoded by DNA viruses.

Authors:  Robson F de Souza; Lakshminarayan M Iyer; L Aravind
Journal:  Biochim Biophys Acta       Date:  2009-10-28

7.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

Review 8.  Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.

Authors:  T Lampejo; D Kavanagh; J Clark; R Goldin; M Osborn; P Ziprin; S Cleator
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

9.  Viral takeover of the host ubiquitin system.

Authors:  Jean K Gustin; Ashlee V Moses; Klaus Früh; Janet L Douglas
Journal:  Front Microbiol       Date:  2011-07-28       Impact factor: 5.640

10.  Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Erik S Knudsen
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.